We analyzed gene expression data from AML patients in The Cancer Genome Atlas dataset (Cancer Genome Atlas Research Network et al, 2013) and found that CDK5, CCNI, and CDK5R1 are robustly expressed, whereas CDK5R2 mRNA could not be detected in the majority of samples (Appendix Fig S6B). This evidence concerns the gene CCNI and acute myeloid leukemia.